Oxomemazine
Specifications
3689-50-7CAS Number
222-996-8EC Number
3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amineIUPAC Name
C18H22N2O2SChemical Formula
330.4 g/molMolecular Weight
Oxomemazine; 3689-50-7; Dysedon; Doxergan; Imakol; Oxomemazina; Oxomemazinum; Oplex; Exe-top; Trimeprazine 5,5-dioxide; RP 6847; RP-6847; 305MB38V1C; 6487-RP; 6847-RP; DTXSID5023405; PHENOTHIAZINE, 10-(3-(DIMETHYLAMINO)-2-METHYLPROPYL)-, 5,5-DIOXIDE; Phenothiazine, 10-[3-(dimethylamino)-2-methylpropyl]-, 5,5-dioxide; (+-)-Oxomemazine; RefChem:857801; DTXCID103405; R06AD08; 10-(3-(dimethylamino)-2-methylpropyl)-10H-5lambda6-phenothiazine-5,5-dione; 222-996-8; Dosegran; Oxymemazine; 10-(3-(diMethylaMino)-2-Methylpropyl)-10H-phenothiazine 5,5-dioxide; Alimemazine S,S-dioxide; (+)-Oxomemazine; (-)-Oxomemazine; MFCD00868197; 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine; Oxomemazine, (+)-; Oxomemazine, (-)-; 10-(3-(Dimethylamino)-2-methylpropyl)phenothiazine 5,5-dioxide; 10-(3-(Dimethylamino)-2-methylpropyl)phenothiazine-5,5-dioxide; Q824SGH3RN; (+/-)-OXOMEMAZINE; 6847 R.P.; 5GP9538P4S; 10H-Phenothiazine-10-propanamine, N,N,.beta.-trimethyl-, 5,5-dioxide; Oxomemazine (INN); OXOMEMAZINE [INN]; 174508-14-6; Oxomemazin; Trimeprazine Sulphone; Oxomemazine; Oxomemazine [INN:DCF]; 10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide; Oxomemazinum [INN-Latin]; Oxomemazina [INN-Spanish]; EINECS 222-996-8; 174508-13-5; NCGC00182075-03; BRN 0289178; UNII-305MB38V1C; 10-[3-(Dimethylamino)-2-methylpropyl]-10H-phenothiazine 5,5-Dioxide; Doxergan (TN); OXOMEMAZINE [MI]; Dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine [French]; UNII-Q824SGH3RN; OXOMEMAZINE [MART.]; OXOMEMAZINE [WHO-DD]; 4-27-00-01270 (Beilstein Handbook Reference); MLS006009989; SCHEMBL423634; UNII-5GP9538P4S; orb1298159; CHEMBL2104734; SCHEMBL29378205; CHEBI:135408; ARD14338; Dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine; Oxomemazine 1.0 mg/ml in Methanol; AKOS015962134; 6487 RP; 6847 RP; DB13820; NCGC00182075-02; AC-15943; DA-76517; MS-24971; SMR004701064; SY244359; HY-136587; CS-0131898; NS00002586; T9353; D07401; F20164; F816758; SR-01000883964; Q3359071; SR-01000883964-1; 10H-Phenothiazine-10-propanamine, N,N,|A-trimethyl-, 5,5-dioxide; 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethyl-propan-1-amine; 10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide, (+)-; 10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide, (-)-; 3-(5,5-Dioxido-10H-phenothiazin-10-yl)-N,N,2-trimethyl-1-propanamine #; 3-(5,5-dioxido-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine; 10-[3-(Dimethylamino)-2-methylpropyl]-5lambda~6~-phenothiazine-5,5(10H)-dione; 10H-PHENOTHIAZINE-10-PROPANAMINE, N,N,.BETA.-TRIMETHYL-, 5,5-DIOXIDE, (+)-; 10H-PHENOTHIAZINE-10-PROPANAMINE, N,N,.BETA.-TRIMETHYL-, 5,5-DIOXIDE, (-)-Synonyms
Products Containing Oxomemazine
TOPLEXIL 0,33 mg/ml, siropTOPLEXIL 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE ZENTIVA 0,33 mg/ml, siropOXOMEMAZINE ZENTIVA 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE VIATRIS 0,33 mg/mL, siropOXOMEMAZINE VIATRIS 0,33 mg/mL SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE UPSA 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE TEVA 0,33 mg/ml, siropOXOMEMAZINE TEVA 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE SANDOZ CONSEIL 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE SANDOZ 0,33 mg/ml, siropOXOMEMAZINE SANDOZ 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassique
Page 1 of 3
Companies Selling Oxomemazine
CT
Công ty Cổ phần Dược Trung ương MediplantexViet NamCT
Công Ty Cổ Phần Dược Phẩm Tv.Pharm Viet Nam
CT
Công Ty TNHH Wooshin Đồng Nai Viet Nam
CT
Công ty cổ phần dược phẩm Gia NguyễnViet Nam
Page 1 of 2